FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/12/078715 [Registered on: 30/12/2024] Trial Registered Prospectively
Last Modified On: 27/12/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda
Other (Specify) [Curative]  
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Clinical study of Tiktadi Ghrita Ointment on stretchmarks in pregnant women 
Scientific Title of Study   Pharmaceutico-analytical study and clinical evaluation of Tiktadi Ghrita Ointment in Kikkisa with special reference to Striae gravidarum: A Randomized Controlled Trial 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Alka Gajanan Khade 
Designation  PG Scholar 
Affiliation  Shri Ayurveda Mahavidyalaya, Nagpur 
Address  Rasashastra and Bhaishajyakalpana Department, Pakwasa Samanvay Rugnalaya, Shri Ayurved Mahavidyalaya, Hanuman Nagar, Nagpur 440024, Maharashtra, India

Nagpur
MAHARASHTRA
440024
India 
Phone  9075677028  
Fax    
Email  alkakhade98@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Raman Belge 
Designation  Head of department 
Affiliation  Shri Ayurveda Mahavidyalaya, Nagpur 
Address  Rasashastra and Bhaishajyakalpana Department, Pakwasa Samanvay Rugnalaya, Shri Ayurved Mahavidyalaya, Hanuman Nagar, Nagpur 440024, Maharashtra, India

Nagpur
MAHARASHTRA
440024
India 
Phone  9822879010  
Fax    
Email  ramanbelge@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Raman Belge 
Designation  Head of department 
Affiliation  Shri Ayurveda Mahavidyalaya, Nagpur 
Address  Rasashastra and Bhaishajyakalpana Department, Pakwasa Samanvay Rugnalaya, Shri Ayurved Mahavidyalaya, Hanuman Nagar, Nagpur 440024, Maharashtra, India

Nagpur
MAHARASHTRA
440024
India 
Phone  9822879010  
Fax    
Email  ramanbelge@gmail.com  
 
Source of Monetary or Material Support  
Pakwasa Samanvay Rugnalaya, Shri Ayurved Mahavidyalaya, Hanuman Nagar, Nagpur,pincode- 440024,Nagpur,Maharashtra, India 
 
Primary Sponsor  
Name  Dr Alka Gajanan Khade 
Address  Rasashastra and Bhaishajyakalpana Department, Pakwasa Samanvay Rugnalaya, Shri Ayurved Mahavidyalaya, Hanuman Nagar, Nagpur 440024, Maharashtra, India 
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Alka Gajanan Khade  Shri Ayurveda Mahavidyalaya,Nagpur  Rasashastra and Bhaishajyakalpana Department, Pakwasa Samanvay Rugnalaya, Shri Ayurved Mahavidyalaya, Hanuman Nagar, Nagpur,pincode- 440024,Nagpur,Maharashtra, India
Nagpur
MAHARASHTRA 
9075677028

alkakhade98@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Shri Ayurveda Mahavidyalaya,Nagpur  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:O268||Other specified pregnancy relatedconditions. Ayurveda Condition: KIKKISA-GARBINIROGAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Comparator ArmDrugClassical(1) Medicine Name: Karveer Taila, Reference: Charak Samhita,Sharir Sthan,Jatisutriya sharir adhyaya 08/32, Route: Topical, Dosage Form: Taila, Dose: 2(ml), Frequency: bd, Bhaishajya Kal: Pragbhakta, Duration: 30 Days, anupAna/sahapAna: No, Additional Information: -
2Intervention ArmDrugOther than Classical(1) Medicine Name: Tiktadi Ghrita Ointment, Reference: NA, Route: Topical, Dosage Form: Malahara/ Ointment/ Balm, Dose: 2(g), Frequency: bd, Bhaishajya Kal: Pragbhakta, Duration: 30 Days, anupAna/sahapAna: No, Additional Information: Tikatdi Ghrita is mentioned in Yogratnakar for Vran savarnikaran.The Tikatdi Ghrita is modified into Tiktadi Ghrita ointment.
 
Inclusion Criteria  
Age From  20.00 Year(s)
Age To  35.00 Year(s)
Gender  Female 
Details  Patients willingly participating in the trial and giving consent form.
• Selection of patient will be Primigravida only.
• Women diagnosed with symptoms of Kikkisa –
1. Vaivarnya (Discoloration)
2. Kandu (Itching)
3. Vidah(Burning sensation)
4. Rekha Swarupa Twak Sankocha (Linear line marking and contractions of the skin in the abdomen). 
 
ExclusionCriteria 
Details  1.Women suffering from any other skin diseases except Kikkisa.
2.Known case of any systemic illness like tuberculosis,HIV, Hepatitis B,
Hepatitis C, Diabetes mellitus, Hyperbilirubinemia,etc
3.Presence of any surgical scar on the abdomen.
4.High-risk pregnancy. (multiple pregnancy, pregnancy induced hypertension, Polyhydramnios, etc.) 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Case Record Numbers 
Blinding/Masking   Participant Blinded 
Primary Outcome  
Outcome  TimePoints 
Pharmaceutico-analytical Studies of Tiktadi Ghrita Ointment  6 Months 
 
Secondary Outcome  
Outcome  TimePoints 
This study may prove Tiktadi Ghrita Ointment as effective treatment in the management of Kikkisa  Follow up on 15th,30th & 45th Day 
 
Target Sample Size   Total Sample Size="64"
Sample Size from India="64" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   10/01/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  
In the present study, total 64 participants will be taken for trial dividing them in 2 equal groups.
Grp-A will receive the trial drug ’Tiktadi Ghrita Ointment’and Grp-B will receive the controlled drug ’Karveer Taila’
for external application for 45 days. Follow up will be taken on Day-15,30,45. Result will be
concluded based on assessment criteria.
 
Close